{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:08:07Z","timestamp":1788847687266,"version":"build-2803163510"},"reference-count":5,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health-Ricerca Corrente to Centro Cardiologico Monzino IRCCS"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/ehjcvp\/pvag069","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T20:28:16Z","timestamp":1788035296000},"source":"Crossref","is-referenced-by-count":0,"title":["Rethinking the CVOT design in an era of high-performing background therapy"],"prefix":"10.1093","author":[{"given":"Nicola","family":"Cosentino","sequence":"first","affiliation":[{"name":"Department of Perioperative Cardiology and Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS , Via C. Parea 4, Milan 20138 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1339-6679","authenticated-orcid":false,"given":"Gianluca","family":"Pontone","sequence":"additional","affiliation":[{"name":"Department of Perioperative Cardiology and Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS , Via C. Parea 4, Milan 20138 ,","place":["Italy"]},{"name":"Department of Biomedical, Surgical and Dental Sciences, University of Milan , Milan 20122 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"key":"2026090801424202100_pvag069-B1","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.126.014205","article-title":"Rationale and design of CARDIO-TTRansform, a phase 3 trial of eplontersen in transthyretin amyloid cardiomyopathy","volume":"19","author":"Masri","year":"2026","journal-title":"Circ Heart Fail"},{"key":"2026090801424202100_pvag069-B2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/jamacardio.2025.4491","article-title":"Rationale and baseline clinical characteristics of the ziltivekimab cardiovascular outcomes trial: interleukin-6 inhibition and atherosclerotic event rate reduction","volume":"11","author":"Ridker","year":"2026","journal-title":"JAMA Cardiol"},{"key":"2026090801424202100_pvag069-B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2608510","article-title":"CARDIO-TTRansform Investigators. Eplontersen for transthyretin amyloid cardiomyopathy","volume-title":"N Engl J Med","author":"Fontana","year":"2026"},{"key":"2026090801424202100_pvag069-B4","author":"Novo Nordisk. Novo Nordisk provides update on the ZEUS phase 3 trial in people with AS CVD, CKD and inflammation"},{"key":"2026090801424202100_pvag069-B5","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","article-title":"Bempedoic acid and cardiovascular outcomes in statin-intolerant patients","volume":"388","author":"Nissen","year":"2023","journal-title":"N Engl J Med"}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcvp\/advance-article-pdf\/doi\/10.1093\/ehjcvp\/pvag069\/70870329\/pvag069.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/advance-article-pdf\/doi\/10.1093\/ehjcvp\/pvag069\/70870329\/pvag069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:42:46Z","timestamp":1788846166000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/advance-article\/doi\/10.1093\/ehjcvp\/pvag069\/8776097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":5,"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvag069","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"value":"2055-6837","type":"print"},{"value":"2055-6845","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]},"article-number":"pvag069"}}